secwatch / observer

8-K filed May 21, 2026, 4:18 PM ET ticker PSBD CIK 0001794776

other material confidence high sentiment positive materiality 0.70

PSBD expands buyback program by $30M, extends to June 2027; plans 10b5-1 plan

Palmer Square Capital BDC Inc.

Board authorized additional $30M for share repurchases, extending program to June 22, 2027.
Plans Rule 10b5-1 repurchase plan for up to $10M when stock price is below NAV per share.
$22.2M in repurchases completed to date under existing program.
CEO states conviction buying at discount to book value drives shareholder returns.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-26-060068
form_type: 8-K
ticker: PSBD
cik: 0001794776
company_name: Palmer Square Capital BDC Inc.
filed_at: 2026-05-21T20:18:54+00:00
discovered_at: 2026-05-21T20:20:00.292872+00:00
generated_at: 2026-05-21T20:21:12.703054+00:00
sec_items: ["8.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-26-060068
json_url: https://secwatch.observer/filing/0001213900-26-060068.json
markdown_url: https://secwatch.observer/filing/0001213900-26-060068.md
text_url: https://secwatch.observer/filing/0001213900-26-060068.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1794776/000121390026060068/0001213900-26-060068-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1794776/000121390026060068/ea0291901-8k_palmer.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

SYRE

Spyre Therapeutics expands SPY003 license field beyond IBD with dosing restrictions until 2028-2030

Spyre Therapeutics, Inc. June 1, 2026, 4:01 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ORKA

Oruka Therapeutics expands ORKA-001 license to include IBD; clinical dosing restrictions until 2028-2030

Oruka Therapeutics, Inc. June 1, 2026, 4:01 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Via Renewables to redeem all 1,884,935 shares of its 8.75% Series A Preferred at $25.00 per share plus dividends

Via Renewables, Inc. June 1, 2026, 3:06 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

BUKS

CEO Christopher Reedy discloses ongoing cancer treatment; remains in role

BUTLER NATIONAL CORP June 1, 2026, 12:41 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CPSH

CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share

CPS TECHNOLOGIES CORP/DE/ June 1, 2026, 9:35 AM ET other_material Items 1.01, 5.03, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

DBX

Dropbox secures $400M revolving credit facility, authorizes $900M share repurchase program

DROPBOX, INC. June 1, 2026, 9:06 AM ET other_material Items 1.01, 2.03, 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CLIR

ClearSign Technologies prices 777,780-share public offering at $4.33/share for ~$3.37M gross proceeds

ClearSign Technologies Corp June 1, 2026, 8:30 AM ET other_material Items 1.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

UFPI

UFP Industries authorizes $300M share repurchase program, replacing prior authorization

UFP INDUSTRIES INC June 1, 2026, 8:17 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001213900-26-060068

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.